130 related articles for article (PubMed ID: 33106144)
1. Cognitive Performance and Neuro-Metabolites in HIV Using 3T Magnetic Resonance Spectroscopy: A Cross-Sectional Study from India.
Gupta K; Shivabalan ; Kumar V; Vyas S; Pandey RM; Jagannathan NR; Sinha S
Curr HIV Res; 2021; 19(2):147-153. PubMed ID: 33106144
[TBL] [Abstract][Full Text] [Related]
2. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
Mohamed MA; Barker PB; Skolasky RL; Selnes OA; Moxley RT; Pomper MG; Sacktor NC
Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
[TBL] [Abstract][Full Text] [Related]
3. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
[TBL] [Abstract][Full Text] [Related]
4. Brain N -acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV.
Wiseman RL; Bigos KL; Dastgheyb RM; Barker PB; Rubin LH; Slusher BS
AIDS; 2024 Jun; 38(7):1003-1011. PubMed ID: 38411600
[TBL] [Abstract][Full Text] [Related]
5. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
7. Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals.
Mora-Peris B; Bouliotis G; Ranjababu K; Clarke A; Post FA; Nelson M; Burgess L; Tiraboschi J; Khoo S; Taylor S; Ashby D; Winston A
AIDS; 2018 May; 32(8):1007-1015. PubMed ID: 29438199
[TBL] [Abstract][Full Text] [Related]
8. Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy adults at 3 Tesla.
Doelken MT; Mennecke A; Stadlbauer A; Kloska S; Struffert T; Engelhorn T; Thuerauf N; Doerfler A; Stefan H; Hammen T
Acad Radiol; 2009 Dec; 16(12):1493-501. PubMed ID: 19781961
[TBL] [Abstract][Full Text] [Related]
9. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
[TBL] [Abstract][Full Text] [Related]
10. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study.
Pathai S; Deshpande A; Gilbert C; Lawn SD
BMC Infect Dis; 2009 Sep; 9():158. PubMed ID: 19775470
[TBL] [Abstract][Full Text] [Related]
12. Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature.
Al-Khindi T; Zakzanis KK; van Gorp WG
J Int Neuropsychol Soc; 2011 Nov; 17(6):956-69. PubMed ID: 21813033
[TBL] [Abstract][Full Text] [Related]
13. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
Sinha S; Gupta K; Tripathy S; Dhooria S; Ranjan S; Pandey RM
BMC Infect Dis; 2017 Dec; 17(1):761. PubMed ID: 29228918
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.
Young AC; Yiannoutsos CT; Hegde M; Lee E; Peterson J; Walter R; Price RW; Meyerhoff DJ; Spudich S
Neurology; 2014 Oct; 83(18):1592-600. PubMed ID: 25261502
[TBL] [Abstract][Full Text] [Related]
15. Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Jahng GH; Oh J; Lee DW; Kim HG; Rhee HY; Shin W; Paik JW; Lee KM; Park S; Choe BY; Ryu CW
J Alzheimers Dis; 2016 Mar; 52(1):145-59. PubMed ID: 27060946
[TBL] [Abstract][Full Text] [Related]
16. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.
Paul RH; Ernst T; Brickman AM; Yiannoutsos CT; Tate DF; Cohen RA; Navia BA; ; ;
J Int Neuropsychol Soc; 2008 Sep; 14(5):725-33. PubMed ID: 18764968
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes.
Cross HM; Combrinck MI; Joska JA
S Afr Med J; 2013 Sep; 103(10):758-62. PubMed ID: 24079630
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
Kumar AM; Ownby RL; Waldrop-Valverde D; Fernandez B; Kumar M
J Neurovirol; 2011 Feb; 17(1):26-40. PubMed ID: 21165787
[TBL] [Abstract][Full Text] [Related]
19. Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls.
Ashby J; Foster C; Garvey L; Wan T; Allsop J; Paramesparan Y; Taylor-Robinson SD; Fidler S; Winston A
HIV Clin Trials; 2015; 16(2):81-7. PubMed ID: 25874990
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.
Mbugua KK; Holmes MJ; Cotton MF; Ratai EM; Little F; Hess AT; Dobbels E; Van der Kouwe AJ; Laughton B; Meintjes EM
AIDS; 2016 Jun; 30(9):1353-62. PubMed ID: 26959509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
